Isradipine decreases the hemodynamic response of cocaine and methamphetamine: Results from two human laboratory studies

American Journal of Hypertension

Volumn 18, Issue 6, 2005, Pages 813-822

  Johnson, Bankole A ^a   Wells, Lynda T ^a   Roache, John D ^b   Wallace, Christopher ^b   Ait Daoud, Nassima ^a   Wang, Yanmei ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Blood pressure; Cocaine; Dopamine; Human beings; Hypertension; Isradipine; Methamphetamine

Indexed keywords

COCAINE; ISRADIPINE; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOPULMONARY HEMODYNAMICS; CARDIOTOXICITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFECT; DRUG INFUSION; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSIVE CRISIS; LOW DRUG DOSE; MALE; METHAMPHETAMINE DEPENDENCE; PRIORITY JOURNAL; PULSE PRESSURE; SUSTAINED RELEASE FORMULATION;

ADULT; AMPHETAMINE-RELATED DISORDERS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; COCAINE; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; INJECTIONS, INTRAVENOUS; ISRADIPINE; MALE; METHAMPHETAMINE;

EID: 19744362939     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.01.020     Document Type: Article

References (45)

1. M.M. Knuepfer Cardiovascular disorders associated with cocaine use myths and truths Pharmacol Ther 97 2003 181 222
2. K.J. Varner, B.A. Ogden, J. Delcarpio, S. Meleg-Smith Cardiovascular responses elicited by the "binge" administration of methamphetamine J Pharmacol Exp Ther 301 2002 152 159
3. US Department of Health and Human Services 2000 National Household Survey on Drug Abuse 2001 The Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies Washington, DC
4. Swan N: Drug abuse cost to society set at $97.7 billion, continuing steady increase since 1975. NIDA Notes, vol. 13, no. 4, November 1998.
5. US Department of Health and Human Services The DAWN Report 2001 The Substance Abuse and Mental Health Services Administration (SAMHSA), Drug Abuse Warning Network (DAWN) Washington, DC
6. G.G. Davis, C.I. Swalwell The incidence of acute cocaine or methamphetamine intoxication in deaths due to ruptured cerebral (berry) aneurysms J Forensic Sci 41 1996 626 628
7. F. Selmi, K.G. Davies, R.R. Sharma, J.W. Neal Intracerebral haemorrhage due to amphetamine abuse report of two cases with underlying arteriovenous malformations Br J Neurosurg 9 1995 93 96
8. S.B. Karch, B.G. Stephens, C.H. Ho Methamphetamine-related deaths in San Francisco demographic, pathologic, and toxicologic profiles J Forensic Sci 44 1999 359 368
9. R.A. Wise Neural mechanisms of the reinforcing action of cocaine NIDA Res Monogr 50 1984 15 33
10. S.E. Hemby, B.A. Johnson, S.I. Dworkin Neurobiological basis of drug reinforcement B.A. Johnson J.D. Roache Drug Addiction and Its Treatment Nexus of Neuroscience and Behavior 1997 Philadelphia Lippincott-Raven 137 169
11. S.R. Tella, S.R. Goldberg Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine Pharmacol Biochem Behav 59 1998 305 312
12. R.G. Williams, K.M. Kavanagh, K.K. Teo Pathophysiology and treatment of cocaine toxicity implications for the heart and cardiovascular system Can J Cardiol 12 1996 1295 1301
13. B. Johnson, D. Overton, L. Wells, P. Kenny, D. Abramson, S. Dhother, Y.R. Chen, P. Bordnick Effects of acute intravenous cocaine on cardiovascular function, human learning, and performance in cocaine addicts Psychiatry Res 77 1998 35 42
14. A.J. Ruttenber, J. Lawler-Heavner, M. Yin, C.V. Wetli, W.L. Hearn, D.C. Mash Fatal excited delirium following cocaine use epidemiologic findings provide new evidence for mechanisms of cocaine toxicity J Forensic Sci 42 1997 25 31
15. J.M. Isner, N.A. Estes 3rd, P.D. Thompson, M.R. Costanzo-Nordin, R. Subramanian, G. Miller, G. Katsas, K. Sweeney, W.Q. Sturner Acute cardiac events temporally related to cocaine abuse N Engl J Med 315 1986 1438 1443
16. L.S. Premkumar Selective potentiation of L-type calcium channel currents by cocaine in cardiac myocytes Mol Pharmacol 56 1999 1138 1142
17. R.W. Simpson, W.D. Edwards Pathogenesis of cocaine-induced ischemic heart disease autopsy findings in a 21-year-old man Arch Pathol Lab Med 110 1986 479 484
18. H.T. Sherief, R.G. Carpentier Electrophysiological mechanisms of cocaine-induced cardiac arrest. A possible cause of sudden cardiac death J Electrocardiol 24 1991 247 255
19. N.C. Morcos, A. Fairhurst, W.L. Henry Direct myocardial effects of cocaine Cardiovasc Res 27 1993 269 273
20. B.A. Bennett, C.K. Hollingsworth, R.S. Martin, J.J. Harp Methamphetamine-induced alterations in dopamine transporter function Brain Res 782 1998 219 227
21. M.W. Fischman Cocaine and the amphetamines H.Y. Meltzer Psychopharmacology The Third Generation of Progress 1987 New York Raven Press 1543 1553
22. A.E. Fleckenstein, J.W. Gibb, G.R. Hanson Differential effects of stimulants on monoaminergic transporters pharmacological consequences and implications for neurotoxicity Eur J Pharmacol 406 2000 1 13
23. M. Perez-Reyes, W.R. White, S.A. McDonald, R.E. Hicks, A.R. Jeffcoat, J.M. Hill, C.E. Cook Clinical effects of daily methamphetamine administration Clin Neuropharmacol 14 1991 352 358
24. B.A. Johnson, N. Ait-Daoud, L.T. Wells Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans Neuropsychopharmacology 22 2000 504 512
25. W.H. Frishman, A. Del Vecchio, S. Sanal, A. Ismail Cardiovascular manifestations of substance abuse part 2: alcohol, amphetamines, heroin, cannabis, and caffeine Heart Dis 5 2003 253 271
26. M.M. Knuepfer, C.A. Branch Calcium channel antagonists reduce the cocaine-induced decrease in cardiac output in a subset of rats J Cardiovasc Pharmacol 21 1993 390 396
27. S.L. Hale, K.J. Alker, S.H. Rezkalla, A.C. Eisenhauer, R.A. Kloner Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine Circulation 83 1991 1437 1443
28. B.H. Negus, J.E. Willard, L.D. Hillis, D.B. Glamann, C. Landau, R.W. Snyder, R.A. Lange Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil Am J Cardiol 73 1994 510 513
29. B. Johnson, L. Wells, P. Kenny, D. Abramson, R. Chen, S. Dhother, D. Overton, P. Bordnick Effects of isradipine on intravenous cocaine-induced cardiovascular response a pilot study Hum Psychopharmacol Clin Exp 14 1999 37 43
30. M. Bignotti, G. Gaudio, G. Gorini, O. Rinaldi, A.M. Grandi, A. Venco Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension Am J Cardiol 72 1993 1301 1304
31. B.A. Johnson, M.A. Javors, Y.-W.F. Lam, L.T. Wells, M. Tiouririne, J.D. Roache, N. Ait-Daoud, K. Lawson Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals Prog Neuropsychopharmacol Biol Psychiatry 29 2005 15 20
32. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 Washington, DC American Psychiatric Association
33. T. Di Paolo Modulation of brain dopamine transmission by sex steroids Rev Neurosci 5 1994 27 41
34. Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y: Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. Int J Neuropsychopharmacol (in press).
35. Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL: Effects of repeated dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol (in press).
36. SAS Institute SAS User's Guide Statistics, Version 9.00 2002 Cary, NC SAS Institute
37. B.A. Johnson, M.D. Devous Sr, P. Ruiz, N. Ait-Daoud Treatment advances for cocaine-induced ischemic stroke focus on dihydropyridine-class calcium channel antagonists Am J Psychiatry 158 2001 1191 1198
38. L. Resnick The cellular ionic basis of hypertension and allied clinical conditions Prog Cardiovasc Dis 42 1999 1 22
39. J.T. Flynn, D.A. Pasko Calcium channel blockers pharmacology and place in therapy of pediatric hypertension Pediatr Nephrol 15 2000 302 316
40. Y.A. Ding, C.L. Han, T.C. Chou, W.Y. Lai, M.F. Shiao Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension J Cardiovasc Pharmacol 19 1992 S32 S37
41. G. Ranieri, V. Filitti, A. Andriani, M.V. Bonfantino, G. Lamontanara, A. Cavallo, M. Milani, R. De Cesaris Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors Cardiovasc Drugs Ther 10 1996 119 123
42. R.N. Brogden, E.M. Sorkin Isradipine an update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension Drugs 49 1995 618 649
43. C.U. Chae, M.A. Pfeffer, R.J. Glynn, G.F. Mitchell, J.O. Taylor, C.H. Hennekens Increased pulse pressure and risk of heart failure in the elderly J Am Med Assoc 281 1999 634 639
44. A.E. Pottieger, P.A. Tressell, H.L. Surratt, J.A. Inciardi, D.D. Chitwood Drug use patterns of adult crack users in street versus residential treatment samples J Psychoact Drugs 27 1995 27 38
45. J. Basile The role of existing and newer calcium channel blockers in the treatment of hypertension J Clin Hypertens 6 2004 621 631